» Articles » PMID: 15452222

Anti-Vpr Activity of a Yeast Chaperone Protein

Abstract

Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) exerts multiple effects on viral and host cellular activities during viral infection, including nuclear transport of the proviral integration complex, induction of cell cycle G(2) arrest, and cell death. In this report, we show that a fission yeast chaperone protein Hsp16 inhibits HIV-1 by suppressing these Vpr activities. This protein was identified through three independent genome-wide screens for multicopy suppressors of each of the three Vpr activities. Consistent with the properties of a heat shock protein, heat shock-induced elevation or overproduction of Hsp16 suppressed Vpr activities through direct protein-protein interaction. Even though Hsp16 shows a stronger suppressive effect on Vpr in fission yeast than in mammalian cells, similar effects were also observed in human cells when fission yeast hsp16 was expressed either in vpr-expressing cells or during HIV-1 infection, indicating a possible highly conserved Vpr suppressing activity. Furthermore, stable expression of hsp16 prior to HIV-1 infection inhibits viral replication in a Vpr-dependent manner. Together, these data suggest that Hsp16 inhibits HIV-1 by suppressing Vpr-specific activities. This finding could potentially provide a new approach to studying the contribution of Vpr to viral pathogenesis and to reducing Vpr-mediated detrimental effects in HIV-infected patients.

Citing Articles

Understanding the molecular mechanisms of human diseases: the benefits of fission yeasts.

Acs-Szabo L, Papp L, Miklos I Microb Cell. 2024; 11:288-311.

PMID: 39104724 PMC: 11299203. DOI: 10.15698/mic2024.08.833.


Single-Agent and Fixed-Dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast ().

Zhang J, Vernon K, Li Q, Benko Z, Amoroso A, Nasr M Pathogens. 2021; 10(7).

PMID: 34202872 PMC: 8308830. DOI: 10.3390/pathogens10070804.


Contribution of yeast models to virus research.

Sahaya Glingston R, Yadav J, Rajpoot J, Joshi N, Nagotu S Appl Microbiol Biotechnol. 2021; 105(12):4855-4878.

PMID: 34086116 PMC: 8175935. DOI: 10.1007/s00253-021-11331-w.


Gene Expression of Pneumocystis murina after Treatment with Anidulafungin Results in Strong Signals for Sexual Reproduction, Cell Wall Integrity, and Cell Cycle Arrest, Indicating a Requirement for Ascus Formation for Proliferation.

Cushion M, Ashbaugh A, Hendrix K, Linke M, Tisdale N, Sayson S Antimicrob Agents Chemother. 2018; 62(5).

PMID: 29463544 PMC: 5923105. DOI: 10.1128/AAC.02513-17.


HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe.

Benko Z, Elder R, Li G, Liang D, Zhao R PLoS One. 2016; 11(3):e0151286.

PMID: 26982200 PMC: 4794156. DOI: 10.1371/journal.pone.0151286.


References
1.
Brenner B, Wainberg M . Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection. Infect Dis Obstet Gynecol. 1999; 7(1-2):80-90. PMC: 1784721. DOI: 10.1155/S1064744999000150. View

2.
Gummuluru S, Emerman M . Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J Virol. 1999; 73(7):5422-30. PMC: 112598. DOI: 10.1128/JVI.73.7.5422-5430.1999. View

3.
Shostak L, Ludlow J, Fisk J, Pursell S, Rimel B, Nguyen D . Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res. 1999; 251(1):156-65. DOI: 10.1006/excr.1999.4568. View

4.
Chang L, Urlacher V, Iwakuma T, Cui Y, Zucali J . Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther. 1999; 6(5):715-28. DOI: 10.1038/sj.gt.3300895. View

5.
Maundrell K . Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene. 1993; 123(1):127-30. DOI: 10.1016/0378-1119(93)90551-d. View